Library Technology Guides

Elsevier and Jisc agree three-year read and publish agreement for UK institutions. Elsevier, a global leader in advanced information and decision support in science and healthcare, today announces a three-year combined read and publish agreement with Jisc - the negotiating body representing UK academic research institutions. The agreement provides participating UK institutions with continued access to Elsevier journals and enables eligible authors to publish open access in Elsevier journals. [Full Announcement].

Elsevier expands ClinicalKey AI with unrivaled full-text knowledge base and technology upgrades to help clinicians make decisions with confidence ​. ClinicalKey AI now includes full-text content from premium journals and medical organizations such as The Lancet, the New England Journal of Medicine, the European Society For Medical Oncology and the American College of Cardiology, offering the broadest collection of trusted medical evidence-based content in a clinical AI solution. [Full Announcement].

Elsevier launches HESI's Personalized Learning Plan to improve nursing students' clinical readiness. Elsevier has launched HESI's Personalized Learning Plan (PLP) in North America to give nursing students and faculty a flexible and smarter learning solution, to help them better prepare for their high-stakes assessments and entry into clinical practice. Using the latest AI capabilities, HESI's PLP features expanded and engaging content that adapts to the specific needs of each student, giving tailored, precise support to help prepare the next generation of nurses. [Full Announcement].

LeapSpace goes live: the Research-Grade AI-Assisted Workspace built on trusted science. LeapSpace, Elsevier's research-grade, AI-assisted workspace, is now live and available to customers. Built on the world's most comprehensive collection of scientific content, LeapSpace helps academic and corporate researchers uncover deeper insights, accelerate innovation, and collaborate seamlessly in one secure environment. It combines multi-model responsible AI with transparency and clear trust markers, industrial-grade data privacy and security, so that every insight is explainable, traceable, and grounded in the highest-quality global science. [Full Announcement].

Elsevier launches LeapSpace: an AI-Assisted workspace to accelerate research and discovery. Elsevier, a global leader in advanced information and decision support in science and healthcare, introduces LeapSpace, a next-generation AI-assisted workspace built to transform how academic and corporate scientists work. Designed for speed, collaboration, and discovery, LeapSpace empowers academic and corporate researchers to uncover deeper insights, accelerate innovation, and collaborate seamlessly - in one secure environment they can trust. [Full Announcement].

Elsevier expands geographical pricing for open access to support greater participation in global research. Elsevier, a global leader in advanced information and decision support in science and healthcare, is expanding its Geographical Pricing for Open Access (GPOA) initiative to an additional 150 gold open access journals, following the success of its 2024 pilot. This expansion means around 300 journals will offer pricing based on geography to help authors in low- and middle-income countries publish their research open access. [Full Announcement].

Elsevier appoints Brent Gordon President of Healthcare Education unit. Elsevier, a global leader in information and analytics for science and healthcare, today announced the appointment of Brent Gordon as president of its global Healthcare Education business unit, which delivers cutting-edge nursing, health, and medical education content through advanced digital learning platforms—empowering the next generation of healthcare professionals and institutions worldwide. Currently, the unit serves more than 10 million learners and future healthcare professionals globally. [Full Announcement].

Redefining Research: Elsevier announces next-generation AI-powered researcher aolution. Elsevier, a global leader in advanced information and decision support in science and healthcare, announced it is developing a next-generation ‘end-to-end' AI-powered solution for academic and corporate researchers, in collaboration with the research community. The solution aims to transform the research workflow - helping scientists move faster from insights to impact while safeguarding reseaFull Announcement].

Elsevier launches PharmaPendium AI, designed to support faster and more reliable access to regulatory insights for drug development. Elsevier, a global information and analytics company, launches PharmaPendium AI, a generative AI assistant for regulatory intelligence in drug development. The solution transforms how regulatory affairs professionals, preclinical and clinical researchers access and apply information from US Food and Drug Administration and European Medicines Agency regulatory documents. PharmaPendium AI, layered on top of PharmaPendium, the company's trusted regulatory tool, delivers citation-backed answers to complex regulatory questions in seconds, helping users move faster with greater confidence. It streamlines the discovery and contextualization of actionable insights using retrieval augmented generation (RAG) and natural language processing. Early access users reported time savings of up to 66% per search and review session, potentially resulting in hundreds of hours saved each year. [Full Announcement].

IGI Global Scientific Publishing partners with ScienceDirect to expand access to its open access journals. IGI Global Scientific Publishing, dedicated to "Publishing Tomorrow's Research Today" since 1988, is pleased to announce a new partnership with ScienceDirect, Elsevier's world-leading platform dedicated to peer-reviewed primary scientific and medical research. Through this collaboration, IGI Global Scientific Publishing's open access journals – indexed in Scopus – will now be hosted on the ScienceDirect platform and accessible via the AI-driven discovery tools on ScienceDirect. This initiative enhances the visibility and accessibility of IGI Global Scientific Publishing's Open Access Journal Program, making articles readily available to ScienceDirect's extensive audience, including libraries and millions of researchers worldwide. [Full Announcement].

Elsevier launches Reaxys AI Search for natural language chemistry queries. Elsevier, a global leader in advanced information and decision support in science and healthcare, has introduced Reaxys AI Search, an innovative addition to the Reaxys platform that leverages AI-driven natural language processing to transform chemistry research. Reaxys is the first chemistry database to introduce natural language document search to enhance the discoverability of relevant documents as researchers navigate vast amounts of complex chemical research information. [Full Announcement].

Elsevier unveils rigorous evaluation framework to mitigate risk in generative AI clinical decision support tools. Elsevier, a global leader in medical information and data analytics, unveiled a groundbreaking evaluation framework for assessing the performance and safety of generative AI-powered clinical reference tools. This innovative approach has been developed for all Elsevier Health generative AI solutions, including ClinicalKey AI, Elsevier's advanced clinical decision support platform, and sets a new standard for responsible AI integration in healthcare. It will be featured in a future issue of the Open Access Journal of the American Medical Informatics Association. The framework, designed with input from clinical subject matter experts across multiple specialties, evaluates AI-generated responses along five critical dimensions: query comprehension, response helpfulness, correctness, completeness, and potential for clinical harm. It serves as a comprehensive assessment to ensure that AI-powered tools not only provide accurate and relevant information but also align with the practical and current needs of healthcare professionals at the point of care. [Full Announcement].

Elsevier launches ScienceDirect AI to transform research with rapid mission-critical insights from trusted content. Elsevier, a global leader in advanced information and decision support, launches ScienceDirect AI, a cutting-edge generative AI tool for researchers. It is designed to transform the way researchers work by enabling them to instantly extract, summarize and compare trusted insights from millions of full-text articles and book chapters on ScienceDirect, the world's largest platform for trusted, peer-reviewed research. Researchers grapple with an ever-growing and overwhelming volume of information and need to quickly get accurate insights they can rely on. Studies show that they spend 25%-35% of their time sifting through literature. ScienceDirect AI helps address this challenge by drawing on the broadest and deepest content set of millions of peer-reviewed full-text research articles and book chapters to generate instant accurate summaries and highlight key findings, while providing references to support the reproducibility and integrity of research. [Full Announcement].

Elsevier Health launches HESI Clinical Practice Readiness Assessment (CPRA): the first assessment of its kind to assess nursing students' practice readiness. Elsevier Health, a global leader in medical information and data analytics, launched HESI Clinical Practice Readiness Assessment the first standardized, objective, and reliable assessment for faculty to assess nursing students' clinical judgment and practice readiness. The Next Generation National Council Licensure Examination (NCLEX®) brings nursing students' clinical judgment to the forefront and has increased the focus on clinical preparedness, an area that studies continually cite as a weakness with new nurses. [Full Announcement].

Elsevier Health launches ClinicalKey AI. Elsevier Health, a global leader in medical information and data analytics, today launched ClinicalKey AI, the first and most advanced clinical decision support tool to be introduced in the US that combines the latest and most trusted medical content with generative artificial intelligence (AI) to help clinicians at the point of care. ClinicalKey AI has been launched in partnership with OpenEvidence, a company specializing in AI for medicine. [Full Announcement].

Elsevier and Washington State University partner to expand open access publishing. Elsevier, a global leader in scientific information and analytics, and Washington State University are pleased to announce a new Read and Publish agreement for 2025. The five-year agreement marks a pioneering step in the Northwest American region, enabling WSU researchers to publish their work open access in Elsevier's journals and ensuring their research is accessible to a global audience. [Full Announcement].

Dutch research institutions and Elsevier announce new agreements. 23 universities of applied science and Elsevier have signed new reading, publishing and Scopus agreements to support the Netherlands' status as an open access leader. Dutch universities, research institutes and Elsevier, a global leader in scientific information and analytics, have signed new agreements to support Dutch research, starting 1 January 2025 and running for two years with an optional extension for a third year. The new read and publish agreement reaffirms the commitment of the research community in the Netherlands to open access. The agreement continues to provide Dutch researchers with reading rights to the peer-reviewed content from Elsevier's portfolio of journals via ScienceDirect [Full Announcement].

Elsevier and the American College of Cardiology expand 40-year partnership to support clinician access to evidence-based guidelines at the point of care. Elsevier Health, a global leader in health information and data analytics, has expanded their partnership with the American College of Cardiology (ACC), the global leader in transforming cardiovascular care and improving heart health for all. The partnership ensures that ACC's Clinical Practice Guidelines and Expert Consensus Decision Pathways on a range of cardiology topics, including heart failure and atrial fibrillation, are made available through ClinicalKey AI, Elsevier's leading generative AI-powered clinical decision support solution. [Full Announcement].

Elsevier appoints Stuart Whayman as President of Corporate Markets. Elsevier, a global leader in scientific information and analytics, announced today the appointment of Stuart Whayman as President of Corporate Markets effective January 6, 2025. Mr. Whayman will report to Kumsal Bayazit, CEO of Elsevier, and will lead the global business that provides advanced scientific and technical information, data and decision support solutions for innovation to R&D-focused organizations across various industries, including pharmaceuticals and chemicals. [Full Announcement].

Elsevier supports Pistoia Alliance in accelerating safe and responsible AI adoption in drug discovery. Elsevier, a global leader in information and analytics, and provider of data and AI-enabled decision support tools for innovation in life sciences, today announced a commitment to support global not-for-profit organization The Pistoia Alliance, which advocates for greater collaboration in the life sciences. The commitment sets out to address common challenges in AI adoption facing the pharmaceutical and research community. Elsevier will provide expertise through a joint program of events for Pistoia's 200+ member organizations, which include top pharmaceutical, biotech, healthcare and R&D organizations as well as regulators. Elsevier has supported the Alliance for more than a decade, helping to equip organizations with the capabilities and tools needed to harness the full potential of AI for effective and efficient drug discovery, in a safe and ethical manner. [Full Announcement].